MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1073/pnas.2620085123

Медицинская библиотека · Proceedings of the National Academy of Sciences of the United States of America · 2026

IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas model.

Saldivia Manuel, Jumani Rajiv S, Thomas Bryanna, Baxley Grace M, Sancheti Jayant, Bullara Domenico, Galarneau Jean-Rene, Cheung Harry, Chen Yen-Liang, DeAsis Reginara Souza, Patra Debjani, René Olivier, Noeske Jonas, Schenk Andreas D, Deniston Colin, Thakore Samarth, Luu Catherine, Wartchow Charles, Koester Dennis C, Francisco Amanda Fortes, Blais Johanne, Jiricek Jan, Hollingsworth Scott A, Gable Jonathan E, Kelly John M, Hochberg Natasha, Knutson Charlie G, Lakshminarayana Suresh B, Sarko Christopher, Manjunatha Ujjini H, Osborne Colin S, Diagana Thierry T, Rao Srinivasa P S

СтатьяПеревод в очереди

Аннотация

Chagas disease is a neglected disease that affects millions of people from the Latin American region. Current nitroheterocyclic therapies suffer from long treatment duration and safety-related treatment discontinuations. A safe, short course therapy would significantly benefit Chagas patients. Here, we report the comprehensive biological, structural, pharmacodynamic, and pharmacokinetic characterization of IID432, an optimized cyanotriazole with superior potency, favorable pharmacokinetics, and improved safety profile compared to the lead compound CT1. IID432 is a fast-acting, parasite-selective topoisomerase II poison that achieves sterile cure after a single oral dose in a murine model of chronic Trypanosoma cruzi infection. Mechanistically, IID432 stabilizes the parasite TcTopoII-DNA cleavage complex by covalently engaging a parasite-specific cysteine (Cys477), thereby conferring selectivity over the human TOP2A. IID432 displays favorable oral pharmacokinetics, with no off-target activity on human topoisomerases. Brief exposure of IID432 rapidly induces parasite-specific DNA damage and produces sterilizing activity in vitro and in vivo without recrudescence. Together, these findings identify IID432 as a first-in-class, parasite-selective covalent topoisomerase poison with a potential to significantly shorten treatment duration for T. cruzi infections.

Для цитирования: Saldivia Manuel, Jumani Rajiv S, Thomas Bryanna, Baxley Grace M, Sancheti Jayant, Bullara Domenico, Galarneau Jean-Rene, Cheung Harry, Chen Yen-Liang, DeAsis Reginara Souza, Patra Debjani, René Olivier, Noeske Jonas, Schenk Andreas D, Deniston Colin, Thakore Samarth, Luu Catherine, Wartchow Charles, Koester Dennis C, Francisco Amanda Fortes, Blais Johanne, Jiricek Jan, Hollingsworth Scott A, Gable Jonathan E, Kelly John M, Hochberg Natasha, Knutson Charlie G, Lakshminarayana Suresh B, Sarko Christopher, Manjunatha Ujjini H, Osborne Colin S, Diagana Thierry T, Rao Srinivasa P S. IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas model.. Proceedings of the National Academy of Sciences of the United States of America. 2026. DOI: 10.1073/pnas.2620085123.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.